TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 7.30E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.20E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 3.40E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 3.10E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 650nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.10E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 185nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 420nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 840nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 71nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 900nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 810nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.30E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 660nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 7.70E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 6.20E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 320nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 860nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 2.20E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 460nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 440nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.10E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 2.30E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 3.00E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.90E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 7.00E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.40E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 3.80E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.60E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 7.80E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.60E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.50E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.70E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 950nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.60E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 2.20E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 7.30E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.40E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 3.70E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 4.30E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 4.30E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 3.70E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 8.80E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 1.70E+4nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 6.80E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Icahn School Of Medicine At Mount Sinai
US Patent
Icahn School Of Medicine At Mount Sinai
US Patent
Affinity DataKd: 4.50E+3nMAssay Description:Compound 1, a 1,3,4-thiadiazine compound identified in a screening assay, was evaluated for testing of in vitro DYRK1A activity at 30 μM concent...More data for this Ligand-Target Pair